Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Colom

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Bioresource Technology|January 4, 2011
On hexenuronic acid (HexA) removal and mediator coupling to pulp fiber in the laccase/mediator treatmentEdith M Cadena, Xueyu Du, Göran Gellerstedt, et al.
Medical Mycology Case Reports|September 15, 2021
<i>Cryptococcus bacillisporus</i> causing cryptococcoma of the beak of an African grey parrot (<i>Psittacus erithacus</i>), PortugalCarolina Silva, Carles Juan-Sallés, Joana Mendes, et al.
Acta Psychiatrica Scandinavica|February 11, 2012
Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patientsA Murru, I Pacchiarotti, A M A Nivoli, et al.
Neuroscience and Biobehavioral Reviews|May 28, 2015
Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illnessJ León-Caballero, I Pacchiarotti, A Murru, et al.
Journal of Clinical Psychopharmacology|October 11, 2001
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderE Vieta, M Reinares, B Corbella, et al.
Actas Espanolas De Psiquiatria|December 16, 2000
[Functional neuroimaging of emotions and bipolar disorder]A Benabarre, E Vieta, F Lomeña, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2009
Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trialF Colom, E Vieta, J Sánchez-Moreno, et al.
Journal of Affective Disorders|October 24, 2012
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidolJ M Goikolea, F Colom, I Torres, et al.
Revista Iberoamericana De Micologia|October 19, 2004
[Epidemiological study of cryptococcosis in Spain: first results]M F Colom, S Frasés, C Ferrer, et al.
Acta Psychiatrica Scandinavica|May 24, 2008
Weight gain in bipolar disorder: pharmacological treatment as a contributing factorC Torrent, B Amann, J Sánchez-Moreno, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Bioresource Technology|January 4, 2011
On hexenuronic acid (HexA) removal and mediator coupling to pulp fiber in the laccase/mediator treatmentEdith M Cadena, Xueyu Du, Göran Gellerstedt, et al.
Medical Mycology Case Reports|September 15, 2021
<i>Cryptococcus bacillisporus</i> causing cryptococcoma of the beak of an African grey parrot (<i>Psittacus erithacus</i>), PortugalCarolina Silva, Carles Juan-Sallés, Joana Mendes, et al.
Acta Psychiatrica Scandinavica|February 11, 2012
Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patientsA Murru, I Pacchiarotti, A M A Nivoli, et al.
Neuroscience and Biobehavioral Reviews|May 28, 2015
Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illnessJ León-Caballero, I Pacchiarotti, A Murru, et al.
Journal of Clinical Psychopharmacology|October 11, 2001
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorderE Vieta, M Reinares, B Corbella, et al.
Actas Espanolas De Psiquiatria|December 16, 2000
[Functional neuroimaging of emotions and bipolar disorder]A Benabarre, E Vieta, F Lomeña, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2009
Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trialF Colom, E Vieta, J Sánchez-Moreno, et al.
Journal of Affective Disorders|October 24, 2012
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidolJ M Goikolea, F Colom, I Torres, et al.
Revista Iberoamericana De Micologia|October 19, 2004
[Epidemiological study of cryptococcosis in Spain: first results]M F Colom, S Frasés, C Ferrer, et al.
Acta Psychiatrica Scandinavica|May 24, 2008
Weight gain in bipolar disorder: pharmacological treatment as a contributing factorC Torrent, B Amann, J Sánchez-Moreno, et al.
Pageof 10